Intercellular Adhesion Molecule 1 (ICAM-1): An Inflammatory Regulator with Potential Implications in Ferroptosis and

Matthew R Miller1, Harold E Landis2, Robert E Miller1

  • 1NutriGenetic Research Institute, Ephrata, PA 17522, USA.

Cells
|September 27, 2024
PubMed

Insights

Intercellular adhesion molecule 1 (ICAM-1) influences ferroptosis, a cell death pathway implicated in Parkinson's disease (PD). Understanding ICAM-1's role in neuroinflammation and glial cells may reveal new therapeutic targets for PD.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Intercellular adhesion molecule 1 (ICAM-1) is a key mediator of leukocyte recruitment and inflammation.
  • Neuroinflammation, involving microglial activation, is central to neurodegenerative diseases like Parkinson's disease (PD).
  • Ferroptosis, an iron-dependent cell death, is increasingly recognized in PD pathogenesis.

Purpose of the Study:

  • To investigate the role of ICAM-1 in Parkinson's disease.
  • To elucidate the mechanisms linking ICAM-1, glial cells, and ferroptosis in the context of PD.

Main Methods:

  • Investigated the expression and function of ICAM-1 in neuroinflammation.
  • Examined the interplay between ICAM-1, glial cells (microglia), and T cells.
  • Assessed the impact of ICAM-1 on ferroptosis pathways relevant to PD.

Main Results:

  • ICAM-1 directly and indirectly influences ferroptosis.
  • Glial cells and T cells mediate ICAM-1's effects on ferroptosis.
  • These interactions are relevant to the progression of Parkinson's disease.

Conclusions:

  • ICAM-1 plays a significant role in the neuroinflammatory processes underlying Parkinson's disease.
  • The interaction between ICAM-1 and ferroptosis, modulated by glial and T cells, presents a potential therapeutic avenue.
  • Further research into these mechanisms could lead to novel interventions for PD.